Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

Similar articles for PubMed (Select 19829081)

1.

Alternative approaches to vaccine delivery.

Wang L, Ma C, Coppel RL.

Hum Vaccin. 2010 Jan;6(1):133-8. Review. No abstract available.

2.

Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery.

Babiuk S, Baca-Estrada M, Babiuk LA, Ewen C, Foldvari M.

J Control Release. 2000 May 15;66(2-3):199-214. Review. Erratum in: J Control Release 2000 Jul 3;67(2-3):415.

PMID:
10742580
3.

Rational design of nasal vaccines.

Slütter B, Hagenaars N, Jiskoot W.

J Drug Target. 2008 Jan;16(1):1-17. doi: 10.1080/10611860701637966 . Review.

PMID:
18172815
4.

Dry powder nasal vaccines as an alternative to needle-based delivery.

Hickey AJ, Garmise RJ.

Crit Rev Ther Drug Carrier Syst. 2009;26(1):1-27. Review.

PMID:
19496746
5.

Implication of nanoparticles/microparticles in mucosal vaccine delivery.

Vyas SP, Gupta PN.

Expert Rev Vaccines. 2007 Jun;6(3):401-18. Review.

PMID:
17542755
6.

Needle-free vaccine delivery.

Kersten G, Hirschberg H.

Expert Opin Drug Deliv. 2007 Sep;4(5):459-74. Review.

PMID:
17880271
7.

New approaches for antigen discovery, production and delivery: vaccines for veterinary and human use.

Potter AA, Babiuk LA.

Curr Drug Targets Infect Disord. 2001 Nov;1(3):249-62. Review.

PMID:
12455399
8.

Foods as production and delivery vehicles for human vaccines.

Korban SS, Krasnyanski SF, Buetow DE.

J Am Coll Nutr. 2002 Jun;21(3 Suppl):212S-217S. Review.

PMID:
12071307
9.

Noninvasive vaccination: from the perspective of sonoporation.

Yuan TF.

Vaccine. 2008 Aug 5;26(33):4109-10. doi: 10.1016/j.vaccine.2008.04.049. Epub 2008 May 9.

PMID:
18502000
10.

[Oral vaccination and vaccine-entrapped microparticle delivery system].

Li FQ, Fei YB, Su H, Hu JH.

Yao Xue Xue Bao. 2007 Mar;42(3):245-51. Review. Chinese.

PMID:
17520821
11.

Delivery strategies to enhance mucosal vaccination.

Chadwick S, Kriegel C, Amiji M.

Expert Opin Biol Ther. 2009 Apr;9(4):427-40. doi: 10.1517/14712590902849224 . Review.

PMID:
19344280
12.

Delivery systems: a vaccine strategy for overcoming mucosal tolerance?

Mann JF, Acevedo R, Campo JD, Pérez O, Ferro VA.

Expert Rev Vaccines. 2009 Jan;8(1):103-12. doi: 10.1586/14760584.8.1.103. Review.

PMID:
19093777
13.

Heterologous prime-boost vaccinations for poverty-related diseases: advantages and future prospects.

Radosević K, Rodriguez A, Lemckert A, Goudsmit J.

Expert Rev Vaccines. 2009 May;8(5):577-92. doi: 10.1586/erv.09.14. Review.

PMID:
19397415
14.

Stimulation of local antibody production: parenteral or mucosal vaccination?

Bouvet JP, Decroix N, Pamonsinlapatham P.

Trends Immunol. 2002 Apr;23(4):209-13. Review.

PMID:
11923116
15.

Pulmonary vaccine delivery.

Lu D, Hickey AJ.

Expert Rev Vaccines. 2007 Apr;6(2):213-26. Review.

PMID:
17408371
16.

Control of transmission with two types of infection.

Ball F, Becker NG.

Math Biosci. 2006 Apr;200(2):170-87. Epub 2006 Feb 21.

PMID:
16494902
17.

[Methods of vaccine administration].

[No authors listed]

Rev Infirm. 1999 Oct;(53):25. French. No abstract available.

PMID:
10797799
18.

Improving vaccine delivery using novel adjuvant systems.

Pichichero ME.

Hum Vaccin. 2008 Jul-Aug;4(4):262-70. Epub 2008 Feb 15. Review.

20.

[Letter: Combination of repeated vaccinations with oral vaccination].

Ehrengut W, Just M, Spiess H.

Anasthesiol Intensivmed Prax. 1975 Oct;11(1):111-2. German. No abstract available.

PMID:
1225067
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk